Tag:
social media
Latest Headlines
Latest Headlines
Scientists follow ‘Facebook’ strategy to corral cancer Big Data
For all their speedy sequencing of genomes, scientists have yet to figure out what all the DNA data mean about diseases, holding back the information from being used in patient treatment.
GutCheck nabs $4M, aids Pfizer with consumer-research software
Denver-based market research startup GutCheck has found $4 million for a Series B round of financing.
10 startups fueling pharma in social media
Slow-moving regulators have kept the rules of engagement on social media platforms fuzzy for pharma players. Yet rather than sit on the sidelines waiting for the FDA to take a firm stance on dos and don'ts, many pharma companies have taken a shot at safe moves in the social realm. Potentially powerful collaboration tools have also attracted pharma groups, bringing scientists, patients and physicians into the same digital arenas to share ideas and partner on research. Read the report >>
Microsoft's Bill Gates backs open R&D in social-media investment
Bill Gates has added his high-profile name and dollars to the open-science movement.
IMS continues cloud deal blitz with 360 Vantage buy
IMS Health has made its third cloud-based acquisition in as many months, snapping up mobile sales and marketing systems provider 360 Vantage. The deal continues IMS' whirlwind push into the cloud that has also seen it snag Appature and Semantelli in the past few months.
Merck targets docs with revamped U.K. website and healthcare apps
Merck's U.K. group has raised its level of play in an industry-wide competition for the attention of physicians as they use the Internet.
MS patients search Internet for info on drugs from Genzyme, Novartis
A survey of so-called health activists by Extrovertic and WEGO Health found that many patients with multiple sclerosis have an "insatiable appetite" for updated information
FTC issues social-media ad rules. Will FDA finally be next?
Tired of sifting through FDA warning letters for ideas about online-advertising boundaries? You're in luck. The Federal Trade Commission has issued new rules for social media and mobile ads.
Boehringer Ingelheim boosts social networking site for 'orphan' lung disease
Boehringer Ingelheim has expanded its reach in the world of digital healthcare via a new collaboration with the patient-focused social networking outfit PatientsLikeMe. The alliance is expected to "enhance" PatientsLikeMe's online community for idiopathic pulmonary fibrosis, an orphan lung disease without a known cause or cure.
FDA grants further glimpse into pharma's Facebook perils
Pharma now has another hint about FDA's attitudes toward social media. In a recent warning letter to supplement maker AMARC Enterprises, FDA took issue with the company's use of Facebook's "Like" feature. Apparently, the company "Liked" a questionable user testimonial--and the agency didn't like it.
